What is Clarix Imaging?
Clarix Imaging is at the forefront of developing advanced intraoperative volumetric specimen imaging systems. Their flagship product, the VSI-360, offers true 3D clarity for breast surgical oncology, enabling direct visualization of lumpectomy specimen margins with high-resolution tissue slices. This technology is designed to significantly improve surgical outcomes for patients undergoing breast cancer treatment by providing healthcare professionals with unparalleled imaging insights. The company's focus is on translating extensive research into practical applications that enhance patient care and physician decision-making.
How much funding has Clarix Imaging raised?
Clarix Imaging has raised a total of $10M across 1 funding round:
Not Disclosed
$10M
Not Disclosed (2023): $10M, investors not publicly disclosed
What's next for Clarix Imaging?
The recent major strategic investment positions Clarix Imaging for accelerated growth and market penetration. This capital infusion is expected to fuel further development of their VSI-360 system, expand their commercial reach within healthcare institutions, and potentially explore new applications for their imaging technology. The enterprise-level funding context suggests a strategic phase focused on scaling operations and solidifying their market position as a leader in intraoperative specimen imaging solutions.
See full Clarix Imaging company page
